1.39 USD
▼-0.01-0.71%
盘后 1.62 0.00%
2026-09-16
市值
$7.91M
市盈率
—
EPS
-3.57
股息率
—
52 周区间
1.38 – 5.71
成交量
61.64K
Beta
1.98
目标价
17.00
52W 低 1.3852W 高 5.71
价格走势
公司简介
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company’s lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. In addition, the company develo...